Fiona Hamilton Marshall
Corporate Officer/Principal at MERCK & CO., INC.
Net worth: 517 410 $ as of 2024-05-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Davis | M | 57 | 10 years | |
| Tom Glocer | M | 63 | 17 years | |
| Caroline Litchfield | F | 55 | 34 years | |
| Dalton Smart | M | 58 | 15 years | |
| Jennifer Zachary | F | 46 | 6 years | |
| Chirfi Guindo | M | 58 | 13 years | |
| Pamela Craig | F | 67 | 9 years | |
| Christine Seidman | M | 71 | 4 years | |
| Kathy Warden | F | 52 | 4 years | |
| Stephen Mayo | M | 62 | 3 years | |
| Mary Coe | F | 57 | 5 years | |
| Inge Thulin | M | 69 | 6 years | |
| Patricia Russo | F | 71 | 29 years | |
| Paul Rothman | M | 65 | 9 years | |
| Risa Lavizzo-Mourey | M | 69 | 4 years | |
| Douglas Baker | M | 65 | 2 years | |
| Joseph Romanelli | M | 50 | 2 years | |
| Jennifer Leeds | M | - |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | - |
| Allan Gabor | M | - | 11 years | |
| Carol Bowden | F | - | 10 years | |
| Brooke Hinkson | F | - | 9 years | |
| Andre Musto | M | - | 10 years | |
| Dave Williams | M | 55 | 4 years | |
| Jannie Oosthuizen | M | - | 3 years | |
| Kelly E. W. Grez | F | - | - | |
| Damini Chokshi | F | - | - | |
| Steven Graziano | M | - | 18 years | |
| Johanna Herrmann | F | - | - | |
| Sylvia A. Ayler | F | - | 3 years | |
| Michael Klobuchar | M | 48 | 3 years | |
| Denise Williams | F | - | 15 years | |
| Peter Dannenbaum | M | - | 7 years | |
| Cristal Downing | M | 55 | 3 years | |
| Richard DeLuca | M | 61 | 13 years | |
| Eric Rubin | M | 65 | 6 years | |
| Glenn Dranoff | M | - |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | - |
| Pamela Eisele | F | - | 15 years | |
| Sanat Chattopadhyay | M | - | 15 years | |
| Scott Brown | M | - |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | - |
| Christian Klee | M | - |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | - |
| Harry Werner Kirsch | M | 59 |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | - |
| Hans Jörg Reinhardt | M | 68 |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | - |
| Jeffrey Donohue | M | - |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | - |
| James Matteucci | M | - | 21 years | |
| Evan M. Beckman | M | - |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | - |
| Dean Li | M | 62 | 7 years | |
| Julie Cunningham | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Philip Gotwals | M | 61 |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | 14 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 48 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Fiona Hamilton Marshall
- Personal Network
